|
Characteristic
|
Non-PCa
|
PCa
|
P
|
|---|
|
Grayscale US
| | | |
|
Echogenicity, n (%)
| | |
0.138
|
|
Hypoechoic
|
46 (40.4)
|
68 (59.6)
| |
|
Other echo
|
7 (70.0)
|
3 (30.0)
| |
|
Margin, n (%)
| | |
< 0.001
|
|
Clear
|
22 (95.7)
|
1 (4.3)
| |
|
Unclear
|
31 (30.7)
|
70 (69.3)
| |
|
Distribution, n (%)
| | |
< 0.001
|
|
Even
|
32 (65.3)
|
17 (34.7)
| |
|
Uneven
|
21 (28.0)
|
54 (72.0)
| |
|
Demarcation of internal and external glands, n (%)
| | |
0.031
|
|
Clear
|
46 (47.9)
|
50 (52.1)
| |
|
Unclear
|
7 (25.0)
|
21 (75.0)
| |
|
Nodule size (mm)
|
13.00 ± 7.26
|
15.52 ± 8.81
|
0.084
|
|
CDUS
| | | |
|
Adler grade, n (%)
| | |
< 0.001
|
|
Adler II–III
|
16 (22.2)
|
56 (77.8)
| |
|
Adler 0–I
|
37 (71.2)
|
15 (28.8)
| |
|
CEUS
| | | |
|
Enhancement patterns, n (%)
| | |
< 0.001
|
|
Synchronous wash-in or out, equal enhancement
|
39 (84.8)
|
7 (15.2)
| |
|
Other patterns
|
14 (17.9)
|
64 (82.1)
| |
|
SE
| | | |
|
SR
|
38.83
|
80.17
|
< 0.001
|
- Other patterns included early wash-in or wash-out and high or low enhancement; late wash-in or wash-out and high or low enhancement
- TRUS transrectal ultrasound, US ultrasound, CEUS contrast-enhanced ultrasound, PCa prostate cancer
